186 related articles for article (PubMed ID: 36357381)
21. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.
Gallardo-Becerra L; Cornejo-Granados F; García-López R; Valdez-Lara A; Bikel S; Canizales-Quinteros S; López-Contreras BE; Mendoza-Vargas A; Nielsen H; Ochoa-Leyva A
Microb Cell Fact; 2020 Mar; 19(1):61. PubMed ID: 32143621
[TBL] [Abstract][Full Text] [Related]
22. An Improved Methodology to Overcome Key Issues in Human Fecal Metagenomic DNA Extraction.
Kumar J; Kumar M; Gupta S; Ahmed V; Bhambi M; Pandey R; Chauhan NS
Genomics Proteomics Bioinformatics; 2016 Dec; 14(6):371-378. PubMed ID: 27888152
[TBL] [Abstract][Full Text] [Related]
23. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
24. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
[TBL] [Abstract][Full Text] [Related]
25. Dynamic Alterations in the Respiratory Tract Microbiota of Patients with COVID-19 and its Association with Microbiota in the Gut.
Shen Y; Yu F; Zhang D; Zou Q; Xie M; Chen X; Yuan L; Lou B; Xie G; Wang R; Yang X; Chen W; Wang Q; Feng B; Teng Y; Dong Y; Huang L; Bao J; Han D; Liu C; Wu W; Liu X; Fan L; Timko MP; Zheng S; Chen Y
Adv Sci (Weinh); 2022 Sep; 9(27):e2200956. PubMed ID: 35780499
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
27. Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts.
Huang X; Hu M; Sun T; Li J; Zhou Y; Yan Y; Xuan B; Wang J; Xiong H; Ji L; Zhu X; Tong T; Ning L; Ma Y; Zhao Y; Ding J; Guo Z; Zhang Y; Fang JY; Hong J; Chen H
Cell Host Microbe; 2023 Nov; 31(11):1930-1943.e4. PubMed ID: 37944495
[TBL] [Abstract][Full Text] [Related]
28. Quantitative microbiome profiling links gut community variation to microbial load.
Vandeputte D; Kathagen G; D'hoe K; Vieira-Silva S; Valles-Colomer M; Sabino J; Wang J; Tito RY; De Commer L; Darzi Y; Vermeire S; Falony G; Raes J
Nature; 2017 Nov; 551(7681):507-511. PubMed ID: 29143816
[TBL] [Abstract][Full Text] [Related]
29. Quality control of microbiota metagenomics by k-mer analysis.
Plaza Onate F; Batto JM; Juste C; Fadlallah J; Fougeroux C; Gouas D; Pons N; Kennedy S; Levenez F; Dore J; Ehrlich SD; Gorochov G; Larsen M
BMC Genomics; 2015 Mar; 16(1):183. PubMed ID: 25887914
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients.
Sun Z; Song ZG; Liu C; Tan S; Lin S; Zhu J; Dai FH; Gao J; She JL; Mei Z; Lou T; Zheng JJ; Liu Y; He J; Zheng Y; Ding C; Qian F; Zheng Y; Chen YM
BMC Med; 2022 Jan; 20(1):24. PubMed ID: 35045853
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases.
Cheng X; Zhang Y; Li Y; Wu Q; Wu J; Park SK; Guo C; Lu J
BMC Microbiol; 2022 Nov; 22(1):274. PubMed ID: 36376804
[TBL] [Abstract][Full Text] [Related]
32. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.
Gu S; Chen Y; Wu Z; Chen Y; Gao H; Lv L; Guo F; Zhang X; Luo R; Huang C; Lu H; Zheng B; Zhang J; Yan R; Zhang H; Jiang H; Xu Q; Guo J; Gong Y; Tang L; Li L
Clin Infect Dis; 2020 Dec; 71(10):2669-2678. PubMed ID: 32497191
[TBL] [Abstract][Full Text] [Related]
33. Incorporating plasmid biology and metagenomics into a holistic model of the human gut microbiome.
Stockdale SR; Hill C
Curr Opin Microbiol; 2023 Jun; 73():102307. PubMed ID: 37002975
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
[TBL] [Abstract][Full Text] [Related]
35. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
36. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
37. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
Brooks EF; Bhatt AS
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33593727
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal microbiota: A predictor of COVID-19 severity?
Neag MA; Vulturar DM; Gherman D; Burlacu CC; Todea DA; Buzoianu AD
World J Gastroenterol; 2022 Dec; 28(45):6328-6344. PubMed ID: 36533107
[TBL] [Abstract][Full Text] [Related]
39. The trans-kingdom battle between donor and recipient gut microbiome influences fecal microbiota transplantation outcome.
Kazemian N; Ramezankhani M; Sehgal A; Khalid FM; Kalkhoran AHZ; Narayan A; Wong GK; Kao D; Pakpour S
Sci Rep; 2020 Oct; 10(1):18349. PubMed ID: 33110112
[TBL] [Abstract][Full Text] [Related]
40. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.
Vestad B; Ueland T; Lerum TV; Dahl TB; Holm K; Barratt-Due A; Kåsine T; Dyrhol-Riise AM; Stiksrud B; Tonby K; Hoel H; Olsen IC; Henriksen KN; Tveita A; Manotheepan R; Haugli M; Eiken R; Berg Å; Halvorsen B; Lekva T; Ranheim T; Michelsen AE; Kildal AB; Johannessen A; Thoresen L; Skudal H; Kittang BR; Olsen RB; Ystrøm CM; Skei NV; Hannula R; Aballi S; Kvåle R; Skjønsberg OH; Aukrust P; Hov JR; Trøseid M;
J Intern Med; 2022 Jun; 291(6):801-812. PubMed ID: 35212063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
